Glenmark Pharmaceuticals on Wednesday said it has received tentative approval from the US health regulator for its generic Dapagliflozin and Saxaglip
from Business Line - Companies https://ift.tt/3f0CMW6
from Business Line - Companies https://ift.tt/3f0CMW6
Comments
Post a Comment